Rigel Pharmaceuticals, Inc. (RIGL)
34.15
+0.93
(+2.80%)
USD |
NASDAQ |
Feb 06, 16:00
34.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (TTM) : 115.43M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 74.62M |
| Ironwood Pharmaceuticals, Inc. | 96.29M |
| BioMarin Pharmaceutical, Inc. | 973.41M |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Amicus Therapeutics, Inc. | 353.07M |